Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in Atherosclerosis Retrieve available abstracts of 127 articles: HTML format

Single Articles

November 2021
1. CANDREVA A, Pagnoni M, Rizzini ML, Mizukami T, et al
   Risk of myocardial infarction based on endothelial shear stress analysis using coronary angiography.
   Atherosclerosis. 2021 Nov 16. pii: S0021-9150(21)01437.
   PubMed     Abstract available
   
   
   
2. VERDOIA M, De Luca G
   Reply to: "Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead".
   Atherosclerosis. 2021;336:49-50.
   PubMed    
   
   
   
3. ZUIN M, Rigatelli G, Zuliani G, Roncon L, et al
   Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead.
   Atherosclerosis. 2021;336:48.
   PubMed    
   
   
   
4. WANG FM, Yang C, Ballew SH, Kalbaugh CA, et al
   Ankle-brachial index and subsequent risk of incident and recurrent cardiovascular events in older adults: The Atherosclerosis Risk in Communities (ARIC) study.
   Atherosclerosis. 2021;336:39-47.
   PubMed     Abstract available
   
   
   October 2021
5. MAHENDIRAN T, Klingenberg R, Nanchen D, Gencer B, et al
   CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients.
   Atherosclerosis. 2021;335:77-83.
   PubMed     Abstract available
   
   
   
6. MARTINEZ-CEBALLOS MA, Sinning Rey JC, Alzate-Granados JP, Mendoza-Pinto C, et al
   Coronary calcium in autoimmune diseases: A systematic literature review and meta-analysis.
   Atherosclerosis. 2021;335:68-76.
   PubMed     Abstract available
   
   
   
7. KIM H, Park JT, Lee J, Jung JY, et al
   The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease.
   Atherosclerosis. 2021;335:53-61.
   PubMed     Abstract available
   
   
   
8. DOBIASOVA M
   Correspondence to: "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors".
   Atherosclerosis. 2021;335:148.
   PubMed    
   
   
   
9. NEGRINI S, von Eckardstein A
   Reply to: "Correspondence to: "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors"".
   Atherosclerosis. 2021;335:149.
   PubMed    
   
   
   
10. VENKATARAMAN P, Huynh Q, Nicholls SJ, Stanton T, et al
    Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trial.
    Atherosclerosis. 2021;334:57-65.
    PubMed     Abstract available
    
    
    
11. HAQUE W, Grandhi GR, Kanaya AM, Kandula NR, et al
    Implications of the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines and potential value of the coronary artery calcium score among South Asians in the US: The Mediators of Atherosclerosis in South Asians Li
    Atherosclerosis. 2021;334:48-56.
    PubMed     Abstract available
    
    
    
12. BAMBAGIONI G, Di Mario C, Torguson R, Demola P, et al
    Lipid-rich plaques detected by near-infrared spectroscopy predict coronary events irrespective of age: A Lipid Rich Plaque sub-study.
    Atherosclerosis. 2021;334:17-22.
    PubMed     Abstract available
    
    
    
13. AHMED AI, Han Y, Al Rifai M, Alnabelsi T, et al
    Added prognostic value of plaque burden to computed tomography angiography and myocardial perfusion imaging.
    Atherosclerosis. 2021;334:9-16.
    PubMed     Abstract available
    
    
    September 2021
14. KRISTIANSEN O, Sverre E, Peersen K, Fagerland MW, et al
    The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease.
    Atherosclerosis. 2021;336:23-29.
    PubMed     Abstract available
    
    
    
15. LIU Y, Liu S, Zhao Z, Song X, et al
    Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease.
    Atherosclerosis. 2021;333:75-82.
    PubMed     Abstract available
    
    
    
16. AGBAEDENG TA, Noubiap JJ, Mofo Mato EP, Chew DP, et al
    Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.
    Atherosclerosis. 2021;333:48-55.
    PubMed     Abstract available
    
    
    
17. ALI HJ, Al-Mallah MH
    Time for sex specific atherosclerosis risk prediction.
    Atherosclerosis. 2021;333:87-88.
    PubMed    
    
    
    
18. PEPE M, Napoli G, Carulli E, Moscarelli M, et al
    Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis?
    Atherosclerosis. 2021;333:24-31.
    PubMed     Abstract available
    
    
    
19. USUI E, Matsumura M, Mintz GS, Zhou Z, et al
    Clinical outcomes of low-intensity area without attenuation and cholesterol crystals in non-culprit lesions assessed by optical coherence tomography.
    Atherosclerosis. 2021;332:41-47.
    PubMed     Abstract available
    
    
    
20. VERNON ST, Kott KA, Hansen T, Zhang KJ, et al
    Coronary artery disease burden in women poorly explained by traditional risk factors: Sex disaggregated analyses from the BioHEART-CT study.
    Atherosclerosis. 2021;333:100-107.
    PubMed     Abstract available
    
    
    August 2021
21. SATO R, Okada K, Akiyama E, Konishi M, et al
    Impact of sarcopenic obesity on long-term clinical outcomes after ST-segment elevation myocardial infarction.
    Atherosclerosis. 2021 Aug 27. pii: S0021-9150(21)01294.
    PubMed     Abstract available
    
    
    
22. DYRBUS K, Gasior M, Desperak P, Trzeciak P, et al
    Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry.
    Atherosclerosis. 2021;333:16-23.
    PubMed     Abstract available
    
    
    
23. SILVIS MJM, Fiolet ATL, Opstal TSJ, Dekker M, et al
    Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy.
    Atherosclerosis. 2021;334:93-100.
    PubMed     Abstract available
    
    
    
24. LIU HH, Li S, Cao YX, Guo YL, et al
    Association of triglyceride-rich lipoprotein-cholesterol with recurrent cardiovascular events in statin-treated patients according to different inflammatory status.
    Atherosclerosis. 2021;330:29-35.
    PubMed     Abstract available
    
    
    
25. GOUDA P, Ramasundarahettige C, Anand S, Muhlhoffer E, et al
    Clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: A post hoc analysis of the COMPASS trial.
    Atherosclerosis. 2021;331:38-44.
    PubMed     Abstract available
    
    
    July 2021
26. DE LUCA G, Debel N, Cercek M, Jensen LO, et al
    Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry.
    Atherosclerosis. 2021;332:48-54.
    PubMed     Abstract available
    
    
    
27. LIAN XJ, Dai YN, Xue JH, Zeng LH, et al
    Ticagrelor and the risk of infections during hospitalization in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
    Atherosclerosis. 2021;331:6-11.
    PubMed     Abstract available
    
    
    
28. SCOCCIA A, Gallone G, Cereda A, Palmisano A, et al
    Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19.
    Atherosclerosis. 2021;328:136-143.
    PubMed     Abstract available
    
    
    
29. SHIBUTANI H, Fujii K, Ueda D, Kawakami R, et al
    Automated classification of coronary atherosclerotic plaque in optical frequency domain imaging based on deep learning.
    Atherosclerosis. 2021;328:100-105.
    PubMed     Abstract available
    
    
    
30. VACCARINO V, Shah AJ, Mehta PK, Pearce B, et al
    Brain-heart connections in stress and cardiovascular disease: Implications for the cardiac patient.
    Atherosclerosis. 2021;328:74-82.
    PubMed     Abstract available
    
    
    
31. KOYAMA S, Yamashita A, Matsuura Y, Saito Y, et al
    Intracellular glutamine level determines vascular smooth muscle cell-derived thrombogenicity.
    Atherosclerosis. 2021;328:62-73.
    PubMed     Abstract available
    
    
    
32. BOS MM, de Vries L, Rensen PC, Willems van Dijk K, et al
    Apolipoprotein E genotype, lifestyle and coronary artery disease: Gene-environment interaction analyses in the UK Biobank population.
    Atherosclerosis. 2021;328:33-37.
    PubMed     Abstract available
    
    
    
33. ZHENG YY, Wu TT, Guo QQ, Chen Y, et al
    Long-term dual antiplatelet-induced intestinal injury resulting in translocation of intestinal bacteria into blood circulation increased the incidence of adverse events after PCI in patients with coronary artery disease.
    Atherosclerosis. 2021;328:1-10.
    PubMed     Abstract available
    
    
    June 2021
34. GOLUB I, Lakshmanan S, Dahal S, Budoff MJ, et al
    Utilizing coronary artery calcium to guide statin use.
    Atherosclerosis. 2021;326:17-24.
    PubMed     Abstract available
    
    
    
35. RAGGI P
    Healthy ageing to guide targeted versus universal treatment: A different approach to prevention.
    Atherosclerosis. 2021;326:45-46.
    PubMed    
    
    
    
36. RAZAVI AC, Kelly TN, Budoff MJ, Bazzano LA, et al
    Atherosclerotic cardiovascular disease events among statin eligible individuals with and without long-term healthy arterial aging.
    Atherosclerosis. 2021;326:56-62.
    PubMed     Abstract available
    
    
    May 2021
37. HONDA Y, Mok Y, Mathews L, Hof JRV, et al
    Psychosocial factors and subsequent risk of hospitalizations with peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Atherosclerosis. 2021 May 9. pii: S0021-9150(21)00223.
    PubMed     Abstract available
    
    
    
38. WANG L, Zhou W, Guo M, Hua Y, et al
    The gut microbiota is associated with clinical response to statin treatment in patients with coronary artery disease.
    Atherosclerosis. 2021;325:16-23.
    PubMed     Abstract available
    
    
    
39. VILAHUR G, Sutelman P, Mendieta G, Ben-Aicha S, et al
    Triglyceride-induced cardiac lipotoxicity is mitigated by Silybum marianum.
    Atherosclerosis. 2021;324:91-101.
    PubMed     Abstract available
    
    
    
40. CHO H, Kang SJ, Min HS, Lee JG, et al
    Intravascular ultrasound-based deep learning for plaque characterization in coronary artery disease.
    Atherosclerosis. 2021;324:69-75.
    PubMed     Abstract available
    
    
    
41. WON KB, Heo R, Park HB, Lee BK, et al
    Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors.
    Atherosclerosis. 2021;324:46-51.
    PubMed     Abstract available
    
    
    April 2021
42. WANG Z, Wu J, Zhang D
    Hysterectomy and ischemic heart disease: An observational study using propensity score methods in NHANES 2007-2018.
    Atherosclerosis. 2021;327:5-12.
    PubMed     Abstract available
    
    
    
43. BAINEY KR
    DAPT risk stratification using coronary artery angioscopy at 2 weeks: Personalized medicine at its finest?
    Atherosclerosis. 2021;322:74-76.
    PubMed    
    
    
    
44. ZAFEIROPOULOS S, Farmakis I, Kartas A, Arvanitaki A, et al
    Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial.
    Atherosclerosis. 2021;323:37-43.
    PubMed     Abstract available
    
    
    
45. TUFARO V, Safi H, Torii R, Koo BK, et al
    Wall shear stress estimated by 3D-QCA can predict cardiovascular events in lesions with borderline negative fractional flow reserve.
    Atherosclerosis. 2021;322:24-30.
    PubMed     Abstract available
    
    
    
46. KITAHARA S, Kataoka Y, Miura H, Nishii T, et al
    The feasibility and limitation of coronary computed tomographic angiography imaging to identify coronary lipid-rich atheroma in vivo: Findings from near-infrared spectroscopy analysis.
    Atherosclerosis. 2021;322:1-7.
    PubMed     Abstract available
    
    
    March 2021
47. KUMAR A, Giannopoulos AA, Chatzizisis YS
    The stenotic vulnerable plaque: Identifying the substrate of acute coronary syndromes.
    Atherosclerosis. 2021;320:95-97.
    PubMed    
    
    
    
48. GUGLIELMO M, Lin A, Dey D, Baggiano A, et al
    Epicardial fat and coronary artery disease: Role of cardiac imaging.
    Atherosclerosis. 2021;321:30-38.
    PubMed     Abstract available
    
    
    
49. ARCHER JM, Raggi P, Amin SB, Zhang C, et al
    Season and clinical factors influence epicardial adipose tissue attenuation measurement on computed tomography and may hamper its utilization as a risk marker.
    Atherosclerosis. 2021;321:8-13.
    PubMed     Abstract available
    
    
    
50. NANNA MG, Peterson ED, Chiswell K, Overton RA, et al
    The incremental value of angiographic features for predicting recurrent cardiovascular events: Insights from the Duke Databank for Cardiovascular Disease.
    Atherosclerosis. 2021;321:1-7.
    PubMed     Abstract available
    
    
    
51. SHI F, Sun L, Kaptoge S
    Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis.
    Atherosclerosis. 2021;320:70-78.
    PubMed     Abstract available
    
    
    
52. KLINGENBERG R, Aghlmandi S, Gencer B, Nanchen D, et al
    Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events.
    Atherosclerosis. 2021;320:31-37.
    PubMed     Abstract available
    
    
    
53. VARSHNEY AS, Coskun AU, Siasos G, Maynard CC, et al
    Spatial relationships among hemodynamic, anatomic, and biochemical plaque characteristics in patients with coronary artery disease.
    Atherosclerosis. 2021;320:98-104.
    PubMed     Abstract available
    
    
    February 2021
54. KISANUKI K, Muraki I, Yamagishi K, Kokubo Y, et al
    Weight change during middle age and risk of stroke and coronary heart disease: The Japan Public Health Center-based Prospective Study.
    Atherosclerosis. 2021;322:67-73.
    PubMed     Abstract available
    
    
    
55. KEDHI E, Verdoia M, Suryapranata H, Damen S, et al
    Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.
    Atherosclerosis. 2021;321:39-44.
    PubMed     Abstract available
    
    
    
56. CALIGIURI G, Mallat Z
    "Plaque erosion" or the danger of eerily quiet appearance.
    Atherosclerosis. 2021;318:43-44.
    PubMed    
    
    
    
57. SATO Y, Finn AV, Virmani R
    Calcified nodule: A rare but important cause of acute coronary syndrome with worse clinical outcomes.
    Atherosclerosis. 2021;318:40-42.
    PubMed    
    
    
    
58. RAGGI P, Abele J
    Molecular imaging for risk prediction of coronary artery disease: A close or far fetched option?
    Atherosclerosis. 2021;319:118-120.
    PubMed    
    
    
    
59. COENEN DM, Heinzmann ACA, Karel MFA, Cosemans JMEM, et al
    The multifaceted contribution of platelets in the emergence and aftermath of acute cardiovascular events.
    Atherosclerosis. 2021;319:132-141.
    PubMed     Abstract available
    
    
    
60. DE WINTER RW, Schumacher SP, Stuijfzand WJ, van Diemen PA, et al
    Evolution of coronary artery calcium and absolute myocardial perfusion after percutaneous revascularization: A 3-year serial hybrid [(15)O]H2O PET/CT imaging study.
    Atherosclerosis. 2021;318:22-31.
    PubMed     Abstract available
    
    
    
61. MONTONE RA, Meucci MC, De Vita A, Lanza GA, et al
    Coronary provocative tests in the catheterization laboratory: Pathophysiological bases, methodological considerations and clinical implications.
    Atherosclerosis. 2021;318:14-21.
    PubMed     Abstract available
    
    
    
62. MAJEED K, Bellinge JW, Butcher SC, Alcock R, et al
    Coronary (18)F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome.
    Atherosclerosis. 2021;319:142-148.
    PubMed     Abstract available
    
    
    
63. SUGANE H, Kataoka Y, Otsuka F, Nakaoku Y, et al
    Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule.
    Atherosclerosis. 2021;318:70-75.
    PubMed     Abstract available
    
    
    
64. TAMARAPPOO BK, Lin A, Commandeur F, McElhinney PA, et al
    Machine learning integration of circulating and imaging biomarkers for explainable patient-specific prediction of cardiac events: A prospective study.
    Atherosclerosis. 2021;318:76-82.
    PubMed     Abstract available
    
    
    
65. GREGORY FRANCK
    Role of mechanical stress and neutrophils in the pathogenesis of plaque erosion.
    Atherosclerosis. 2021;318:60-69.
    PubMed     Abstract available
    
    
    
66. COLLET C, Conte E, Mushtaq S, Brouwers S, et al
    Reviewing imaging modalities for the assessment of plaque erosion.
    Atherosclerosis. 2021;318:52-59.
    PubMed     Abstract available
    
    
    
67. VERGALLO R, Jang IK, Crea F
    New prediction tools and treatment for ACS patients with plaque erosion.
    Atherosclerosis. 2021;318:45-51.
    PubMed     Abstract available
    
    
    January 2021
68. OHGAKU A, Fukamachi D, Takahashi K, Tamiya R, et al
    Absence of coronary angioscopy-derived in-stent thrombi is associated with major bleeding events in acute myocardial infarction.
    Atherosclerosis. 2021;319:62-71.
    PubMed     Abstract available
    
    
    
69. GERMAN CA, Shapiro MD
    Statins and coronary artery calcium: What's the score?
    Atherosclerosis. 2021;316:71-72.
    PubMed    
    
    
    
70. AUER J, Auer L
    Stent selection in patients with NSTEMI and risk of incident heart failure.
    Atherosclerosis. 2021;316:66-68.
    PubMed    
    
    
    
71. AL RIFAI M, Kanaya AM, Kandula NR, Cainzos-Achirica M, et al
    Distribution of calcium volume, density, number, and type of coronary vessel with calcified plaque in South Asians in the US and other race/ethnic groups: The MASALA and MESA studies.
    Atherosclerosis. 2021;317:16-21.
    PubMed     Abstract available
    
    
    
72. GAO Y, Lou Y, Liu Y, Wu S, et al
    The relationship between residual cholesterol risk and plaque characteristics in patients with acute coronary syndrome: Insights from an optical coherence tomography study.
    Atherosclerosis. 2021;317:10-15.
    PubMed     Abstract available
    
    
    
73. HEFFRON SP, Ruuth MK, Xia Y, Hernandez G, et al
    Low-density lipoprotein aggregation predicts adverse cardiovascular events in peripheral artery disease.
    Atherosclerosis. 2021;316:53-57.
    PubMed     Abstract available
    
    
    
74. BITTNER DO, Goeller M, Dey D, Zopf Y, et al
    High levels of eicosapentaenoic acid are associated with lower pericoronary adipose tissue attenuation as measured by coronary CTA.
    Atherosclerosis. 2021;316:73-78.
    PubMed     Abstract available
    
    
    
75. OSEI AD, Mirbolouk M, Berman D, Budoff MJ, et al
    Prognostic value of coronary artery calcium score, area, and density among individuals on statin therapy vs. non-users: The coronary artery calcium consortium.
    Atherosclerosis. 2021;316:79-83.
    PubMed     Abstract available
    
    
    December 2020
76. SVENDSEN K, Krogh HW, Igland J, Tell GS, et al
    2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia.
    Atherosclerosis. 2020;319:28-34.
    PubMed     Abstract available
    
    
    
77. ZDANYTE M, Wrazidlo RW, Kaltenbach S, Groga-Bada P, et al
    Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores.
    Atherosclerosis. 2020;318:1-7.
    PubMed     Abstract available
    
    
    
78. PURSNANI S, Merchant M
    South Asian ethnicity as a risk factor for coronary heart disease.
    Atherosclerosis. 2020;315:126-130.
    PubMed     Abstract available
    
    
    
79. OORNI K, Jauhiainen M, Kovanen PT
    Why and how increased plasma ceramides predict future cardiovascular events?
    Atherosclerosis. 2020;314:71-73.
    PubMed    
    
    
    
80. GUPTA M
    Addressing atherosclerotic cardiovascular disease risk in South Asians: A daunting task ahead.
    Atherosclerosis. 2020;315:76-78.
    PubMed    
    
    
    November 2020
81. PEREZ DE ISLA L, Alonso R, Gomez de Diego JJ, Muniz-Grijalvo O, et al
    Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study.
    Atherosclerosis. 2020 Nov 18. pii: S0021-9150(20)31521.
    PubMed     Abstract available
    
    
    
82. KEDHI E, Delewi R, Fabris E, De Luca G, et al
    Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials.
    Atherosclerosis. 2020;315:55-61.
    PubMed     Abstract available
    
    
    October 2020
83. LIN CF, Chang YH, Yu FC, Tsai CT, et al
    Risk of heart failure following drug-eluting stent implantation in patients with non-ST-elevation myocardial infarction.
    Atherosclerosis. 2020 Oct 10. pii: S0021-9150(20)30575.
    PubMed     Abstract available
    
    
    
84. BELL S, Gibson JT, Harshfield EL, Markus HS, et al
    Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study.
    Atherosclerosis. 2020;313:111-117.
    PubMed     Abstract available
    
    
    
85. GAMBARDELLA J, Wang X, Mone P, Khondkar W, et al
    Genetics of adrenergic signaling drives coronary artery calcification.
    Atherosclerosis. 2020;310:88-90.
    PubMed    
    
    
    
86. VAN ROSENDAEL AR, Cainzos-Achirica M, Al-Mallah MH
    Calcified plaque morphology, density, and risk.
    Atherosclerosis. 2020;311:100-102.
    PubMed    
    
    
    September 2020
87. CHALIKIAS G, Serif L, Thomaidis A, Lantzouraki A, et al
    Comparison of novel LDL cholesterol equations in myocardial infarction patients: Clinical impact on risk re-classification and lipid treatment goals on secondary prevention.
    Atherosclerosis. 2020;313:96-101.
    PubMed     Abstract available
    
    
    
88. LIU X, Wu S, Song Q, Wang X, et al
    Visit-to-visit variability of lipid measurements and the risk of myocardial infarction and all-cause mortality: A prospective cohort study.
    Atherosclerosis. 2020 Sep 9. pii: S0021-9150(20)30493.
    PubMed     Abstract available
    
    
    
89. ZHANG M, Liu HH, Jin JL, Yan XN, et al
    Lipoprotein(a) and cardiovascular death in oldest-old (>/=80 years) patients with acute myocardial infarction: A prospective cohort study.
    Atherosclerosis. 2020;312:54-59.
    PubMed     Abstract available
    
    
    
90. LANGSTED A, Bojesen SE, Stroes ESG, Nordestgaard BG, et al
    AHRR hypomethylation as an epigenetic marker of smoking history predicts risk of myocardial infarction in former smokers.
    Atherosclerosis. 2020;312:8-15.
    PubMed     Abstract available
    
    
    
91. MAJEED K, Hillis GS, Schultz CJ
    A "light based biopsy" for high-risk atherosclerotic plaque.
    Atherosclerosis. 2020;309:65-66.
    PubMed    
    
    
    
92. BARTON DE, Hamilos M, Chatzizisis YS
    Left main percutaneous coronary intervention versus coronary artery bypass surgery: A case of true equivalence in low and intermediate complexity anatomy or a question yet to be answered?
    Atherosclerosis. 2020;308:45-47.
    PubMed    
    
    
    August 2020
93. SHITOLE SG, Kuniholm MH, Hanna DB, Boucher T, et al
    Association of human immunodeficiency virus and hepatitis C virus infection with long-term outcomes post-ST segment elevation myocardial infarction in a disadvantaged urban community.
    Atherosclerosis. 2020;311:60-66.
    PubMed     Abstract available
    
    
    
94. SHROFF GR, Sanchez OA, Miedema MD, Kramer H, et al
    Coronary artery calcium progresses rapidly and discriminates incident cardiovascular events in chronic kidney disease regardless of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2020;310:75-82.
    PubMed     Abstract available
    
    
    
95. BELLASI A, Di Lullo L, Raggi P
    Is peritoneal dialysis superior to hemodialysis as far as cardiovascular risk? Another unsolved dilemma for maintenance dialysis.
    Atherosclerosis. 2020;307:75-77.
    PubMed    
    
    
    July 2020
96. FUKUMOTO K, Takemoto Y, Yoshikawa J, Norioka N, et al
    Predictors of endothelial function improvement in patients with mild hypertriglyceridemia without evidence of coronary artery disease treated with purified eicosapentaenoic acid.
    Atherosclerosis. 2020;309:27-32.
    PubMed     Abstract available
    
    
    
97. GULIZIA MM, Maggioni AP, Abrignani MG, Bilato C, et al
    Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
    Atherosclerosis. 2020;308:32-38.
    PubMed     Abstract available
    
    
    May 2020
98. SENONER T, Plank F, Barbieri F, Beyer C, et al
    Added value of high-risk plaque criteria by coronary CTA for prediction of long-term outcomes.
    Atherosclerosis. 2020;300:26-33.
    PubMed     Abstract available
    
    
    
99. DE NISCO G, Hoogendoorn A, Chiastra C, Gallo D, et al
    The impact of helical flow on coronary atherosclerotic plaque development.
    Atherosclerosis. 2020;300:39-46.
    PubMed     Abstract available
    
    
    April 2020
100. BJERRE M, Hilden J, Winkel P, Jensen GB, et al
     Serum osteoprotegerin as a long-term predictor for patients with stable coronary artery disease and its association with diabetes and statin treatment: A CLARICOR trial 10-year follow-up substudy.
     Atherosclerosis. 2020;301:8-14.
     PubMed     Abstract available
     
     
     
101. CHEN Q, Li Q, Li D, Chen X, et al
     Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease.
     Atherosclerosis. 2020;299:45-52.
     PubMed     Abstract available
     
     
     
102. KARJALAINEN MK, Holmes MV, Wang Q, Anufrieva O, et al
     Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study.
     Atherosclerosis. 2020;299:56-63.
     PubMed     Abstract available
     
     
     March 2020
103. PANG J, Abraham A, Vargas-Garcia C, Bates TR, et al
     An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemia.
     Atherosclerosis. 2020;298:52-57.
     PubMed     Abstract available
     
     
     
104. MORELLI MB, Santulli G, Gambardella J
     Calcium supplements: Good for the bone, bad for the heart? A systematic updated appraisal.
     Atherosclerosis. 2020;296:68-73.
     PubMed    
     
     
     
105. MAZIDI M, Katsiki N, Mikhailidis DP, Banach M, et al
     Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies.
     Atherosclerosis. 2020;296:49-58.
     PubMed     Abstract available
     
     
     
106. ADINOLFI LE, Petta S, Fracanzani AL, Coppola C, et al
     Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study.
     Atherosclerosis. 2020;296:40-47.
     PubMed     Abstract available
     
     
     
107. SIMONETTO C, Heier M, Rospleszcz S, Meisinger C, et al
     Risk for cardiovascular events responds nonlinearly to carotid intima-media thickness in the KORA F4 study.
     Atherosclerosis. 2020;296:32-39.
     PubMed     Abstract available
     
     
     
108. ANZIC DROFENIK A, Vrtovec M, Bozic Mijovski M, Sever M, et al
     Progression of coronary calcium burden and carotid stiffness in patients with essential thrombocythemia associated with JAK2 V617F mutation.
     Atherosclerosis. 2020;296:25-31.
     PubMed     Abstract available
     
     
     
109. LESKELA RL, Torvinen A, Rissanen TT, Virtanen V, et al
     Outcomes of lipid control in secondary prevention of coronary artery disease in Finland: A 24-month follow-up after acute coronary syndrome.
     Atherosclerosis. 2020;296:4-10.
     PubMed     Abstract available
     
     
     
110. LUNDE NN, Gregersen I, Ueland T, Shetelig C, et al
     Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages.
     Atherosclerosis. 2020;296:74-82.
     PubMed     Abstract available
     
     
     
111. GUARALDI G, Milic J, Prandini N, Ligabue G, et al
     (18)Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients.
     Atherosclerosis. 2020;297:127-135.
     PubMed     Abstract available
     
     
     
112. LIM SS, Yang YL, Chen SC, Wu CH, et al
     Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
     Atherosclerosis. 2020;297:40-46.
     PubMed     Abstract available
     
     
     
113. THEN C, Then HL, Lechner A, Thorand B, et al
     Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study.
     Atherosclerosis. 2020;297:1-7.
     PubMed     Abstract available
     
     
     February 2020
114. MIRBOLOUK M, Kianoush S, Dardari Z, Miedema MD, et al
     The association of coronary artery calcium score and mortality risk among smokers: The coronary artery calcium consortium.
     Atherosclerosis. 2020;294:33-40.
     PubMed     Abstract available
     
     
     
115. MUSCOGIURI G, Chiesa M, Trotta M, Gatti M, et al
     Performance of a deep learning algorithm for the evaluation of CAD-RADS classification with CCTA.
     Atherosclerosis. 2020;294:25-32.
     PubMed     Abstract available
     
     
     
116. BLAHA MJ, Cainzos-Achirica M, Dardari Z, Blankstein R, et al
     All-cause and cause-specific mortality in individuals with zero and minimal coronary artery calcium: A long-term, competing risk analysis in the Coronary Artery Calcium Consortium.
     Atherosclerosis. 2020;294:72-79.
     PubMed     Abstract available
     
     
     January 2020
117. CHICHAREON P, Modolo R, Kogame N, Takahashi K, et al
     Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study.
     Atherosclerosis. 2020;295:45-53.
     PubMed     Abstract available
     
     
     
118. BONELLO-PALOT N, Laine M, Cuisset T, Ronchard T, et al
     High prevalence of mutations in perilipin 1 in patients with precocious acute coronary syndrome.
     Atherosclerosis. 2020;293:86-91.
     PubMed     Abstract available
     
     
     
119. ALKHALIL M
     Effects of intensive lipid-lowering therapy on mortality after coronary bypass surgery: A meta-analysis of 7 randomised trials.
     Atherosclerosis. 2020;293:75-78.
     PubMed     Abstract available
     
     
     
120. LEIHERER A, Ebner J, Muendlein A, Brandtner EM, et al
     High betatrophin in coronary patients protects from cardiovascular events.
     Atherosclerosis. 2020;293:62-68.
     PubMed     Abstract available
     
     
     
121. UELAND T, Akerblom A, Ghukasyan T, Michelsen AE, et al
     ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial.
     Atherosclerosis. 2020;293:35-41.
     PubMed     Abstract available
     
     
     
122. LEE JG, Ko J, Hae H, Kang SJ, et al
     Intravascular ultrasound-based machine learning for predicting fractional flow reserve in intermediate coronary artery lesions.
     Atherosclerosis. 2020;292:171-177.
     PubMed     Abstract available
     
     
     
123. KIMURA S, Sugiyama T, Hishikari K, Nakagama S, et al
     Relationship of systemic pentraxin-3 values with coronary plaque components on optical coherence tomography and post-percutaneous coronary intervention outcomes in patients with stable angina pectoris.
     Atherosclerosis. 2020;292:127-135.
     PubMed     Abstract available
     
     
     
124. MUNOZ-TORRERO JFS, Zamorano J, Rico-Martin S, Rivas MD, et al
     Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease.
     Atherosclerosis. 2020;292:84-89.
     PubMed     Abstract available
     
     
     
125. MANCIO J, Barros AS, Conceicao G, Pessoa-Amorim G, et al
     Epicardial adipose tissue volume and annexin A2/fetuin-A signalling are linked to coronary calcification in advanced coronary artery disease: Computed tomography and proteomic biomarkers from the EPICHEART study.
     Atherosclerosis. 2020;292:75-83.
     PubMed     Abstract available
     
     
     
126. COUSELO-SEIJAS M, Agra-Bermejo RM, Fernandez AL, Martinez-Cereijo JM, et al
     High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment.
     Atherosclerosis. 2020;292:60-69.
     PubMed     Abstract available
     
     
     
127. SANDESARA PB, Mehta A, O'Neal WT, Kelli HM, et al
     Clinical significance of zero coronary artery calcium in individuals with LDL cholesterol >/=190mg/dL: The Multi-Ethnic Study of Atherosclerosis.
     Atherosclerosis. 2020;292:224-229.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: